Table 3.
|
MSSA |
MRSA |
||||
---|---|---|---|---|---|---|
|
ED Samples (n = 76; 56 Adult) |
Antibiogram (n = 619) |
ED Samples (n = 101; 70 Adult) |
Antibiogram (n = 473) |
||
Drug | Pediatric% resistant | Adult% resistant | Total% resistant | Pediatric% resistant | Adult% resistant | Total% resistant |
Ciprofloxacin |
0% |
2.9% |
14% |
19.3% |
24.5% |
61% |
Clindamycin |
0% |
14.7 |
NR |
9.7% |
4.1% |
NR |
Erythromycin |
28.6% |
41.2% |
39% |
87.1% |
100% |
92% |
Gentamicin |
0% |
0% |
0% |
0% |
0% |
1% |
Levofloxacin |
0% |
2.9% |
13% |
19.3% |
22.5% |
60% |
Moxifloxacin |
0% |
2.94% |
NR |
NR |
NR |
NR |
Oxacillin
a
|
0% |
0% |
0% |
100% |
100% |
100% |
Penicillin |
85.7% |
82.3% |
NR |
100% |
100% |
NR |
Tetracycline |
14.3% |
5.9% |
5% |
0% |
0% |
2% |
TMP/SMX |
35.7% |
2.9% |
1% |
0% |
0% |
1% |
Vancomycin |
0% |
0% |
0% |
0% |
0% |
0% |
Inducible Clindamycin Resistance | 0% | 14.7% | NR | 3.2% | 4.1% | NR |
Bolded pairs achieved statistical significance (p < 0.05) in chi-square analysis.
MSSA = methicillin-sensitive S. aureus; MRSA = methicillin-resistant S. aureus; TMP/SMX = Trimethoprim/Sulfamethoxazole; NR = Not Reported
a Oxacillin resistance defines MRSA vs. MSSA in this clinical laboratory.